You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 25, 2024

ACETAMINOPHEN AND CODEINE PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Acetaminophen And Codeine Phosphate, and when can generic versions of Acetaminophen And Codeine Phosphate launch?

Acetaminophen And Codeine Phosphate is a drug marketed by Teva, ACI, Actavis Mid Atlantic, Akorn, Chartwell, Chartwell Molecular, Dava Pharms Inc, Genus Lifesciences, Wockhardt Bio Ag, Able, Am Therap, Amneal Pharms Ny, Aurolife Pharma Llc, Duramed Pharms Barr, Elite Labs Inc, Everylife, Fosun Pharma, Halsey, Kv Pharm, Lederle, Mikart, Mutual Pharm, Nostrum Labs Inc, Puracap Pharm, Purepac Pharm, Rhodes Pharms, Roxane, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Valeant Pharm Intl, Vitarine, Warner Chilcott, Watson Labs, Watson Labs Florida, Wes Pharma Inc, and Whiteworth Town Plsn. and is included in eighty-nine NDAs.

The generic ingredient in ACETAMINOPHEN AND CODEINE PHOSPHATE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Codeine Phosphate

A generic version of ACETAMINOPHEN AND CODEINE PHOSPHATE was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.

  Sign Up

Drug patent expirations by year for ACETAMINOPHEN AND CODEINE PHOSPHATE
Recent Clinical Trials for ACETAMINOPHEN AND CODEINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Roxane LaboratoriesPhase 1

See all ACETAMINOPHEN AND CODEINE PHOSPHATE clinical trials

Pharmacology for ACETAMINOPHEN AND CODEINE PHOSPHATE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for ACETAMINOPHEN AND CODEINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 085917-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wes Pharma Inc ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 211610-001 Jun 27, 2019 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Halsey ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 086549-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Duramed Pharms Barr ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 088355-001 Feb 6, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Superpharm ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 089185-001 Oct 18, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mikart ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 089231-001 Mar 3, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.